Zaloguj się

Gotowe bibliografie tematyczne / Interleukin-28

Spis treści

Artykuły w czasopismach
Części książek
Streszczenia konferencji

Gotowa bibliografia na temat „Interleukin-28”

Autor: Grafiati

Data publikacji: 3 czerwca 2025

Data aktualizacji: 31 lipca 2025

Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych

Wybierz rodzaj źródła:

Zobacz listy aktualnych artykułów, książek, rozpraw, streszczeń i innych źródeł naukowych na temat „Interleukin-28”.

Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.

Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.

Artykuły w czasopismach na temat "Interleukin-28"

1

Wolk, Kerstin, Katrin Witte, and Robert Sabat. "Interleukin-28 and Interleukin-29: Novel Regulators of Skin Biology." Journal of Interferon & Cytokine Research 30, no. 8 (2010): 617–28. http://dx.doi.org/10.1089/jir.2010.0064.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Luo, Qin, Yi Liu, Shuang Liu, Yibing Yin, Banglao Xu, and Ju Cao. "Interleukin 28 is a potential therapeutic target for sepsis." Clinical Immunology 205 (August 2019): 29–34. http://dx.doi.org/10.1016/j.clim.2019.05.012.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Kempuraj, D., J. Donelan, S. Frydas, et al. "Interleukin-28 and 29 (IL-28 and IL-29): New Cytokines with Anti-Viral Activities." International Journal of Immunopathology and Pharmacology 17, no. 2 (2004): 103–6. http://dx.doi.org/10.1177/039463200401700201.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Krasnova, T. N., L. M. Samokhodskaya, L. V. Ivanitsky, et al. "Impact of interleukin-10 and interleukin-28 gene polymorphisms on the development and course of lupus nephritis." Terapevticheskii arkhiv 87, no. 6 (2015): 40. http://dx.doi.org/10.17116/terarkh201587640-44.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Lin, Shih-Chang, Chia-Chen Kuo, Jeng-Ting Tsao та Li-Jing Lin. "Profiling the expression of interleukin (IL)-28 and IL-28 receptor α in systemic lupus erythematosus patients". European Journal of Clinical Investigation 42, № 1 (2011): 61–69. http://dx.doi.org/10.1111/j.1365-2362.2011.02557.x.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Naumnik, Wojciech, Elzbieta Chyczewska, Tomasz Izycki, and Jaroslaw Talalaj. "P-28 Interleukin 18 serum concentration during chemotherapy of lung cancer." Lung Cancer 41 (August 2003): S98. http://dx.doi.org/10.1016/s0169-5002(03)91997-0.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Obremski, Kazimierz, Wojciech Trybowski, Paweł Wojtacha, Magdalena Gajęcka, Józef Tyburski, and Łukasz Zielonka. "The Effect of Zearalenone on the Cytokine Environment, Oxidoreductive Balance and Metabolism in Porcine Ileal Peyer’s Patches." Toxins 12, no. 6 (2020): 350. http://dx.doi.org/10.3390/toxins12060350.

Pełny tekst źródła

Streszczenie:

The aim of the present study was to determine the effect of zearalenone (ZEN), administered per os to gilts at doses equivalent to 50%, 100%, and 150% of no-observed-adverse-effect level (NOAEL) values for 14, 28, and 42 days during weaning, on changes in the parameters of the oxidoreductive balance, cytokine secretion, and basal metabolism in ileal Payer’s patches. Immunoenzymatic ELISA tests and biochemical methods were used to measure the concentrations of interleukin 1α, interleukin 1β, interleukin 12/23p40, interleukin 2, interferon γ, interleukin 4, interleukin 6, interleukin 8, tumor ne

Style APA, Harvard, Vancouver, ISO itp.

8

Srinidhi, B. V., G. John Fletcher, Jaiprasath Sachidanantham, et al. "Effect of Interleukin-28B Polymorphism on Interleukin-28 Expression and Immunological Recovery amongst HIV-1-Infected Individuals Following Antiretroviral Therapy." Indian Journal of Medical Microbiology 35, no. 4 (2017): 580–84. http://dx.doi.org/10.4103/ijmm.ijmm_17_299.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Moore, Tiffany A., Adam J. Case, Therese L. Mathews, Crystal Modde Epstein, Katherine Laux Kaiser, and Matthew C. Zimmerman. "Interleukin-17A and Chronic Stress in Pregnant Women at 24–28 Weeks Gestation." Nursing Research 68, no. 2 (2019): 167–73. http://dx.doi.org/10.1097/nnr.0000000000000334.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Wejnaruemarn, Salisa, Sirinporn Suksawatamnuay, Jakapat Vanichanan, Piyawat Komolmit, Sombat Treeprasertsuk, and Kessarin Thanapirom. "Association between serum endocan levels and organ failure in hospitalized patients with cirrhosis." PLOS ONE 19, no. 12 (2024): e0315619. https://doi.org/10.1371/journal.pone.0315619.

Pełny tekst źródła

Streszczenie:

Background & aims Acute-on-chronic liver failure is a syndrome characterized by organ failure and high short-term mortality. The lack of reliable biomarkers for the early detection of acute-on-chronic liver failure is a significant challenge. Endothelial dysfunction plays a key role in the development of organ failure. Serum endocan is a potential new biomarker for endothelial dysfunction. Therefore, this study aimed to assess the association between endocan and organ failure and 28-day mortality in patients with cirrhosis. Methods Hospitalized patients with cirrhosis with and without orga

Style APA, Harvard, Vancouver, ISO itp.

Więcej źródeł

Części książek na temat "Interleukin-28"

1

Romano, M., J. Zemmour, and J. L. Touraine. "PROTHYMOCYTES IN MOUSE FETAL LIVER PRODUCE INTERLEUKIN-2." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-013.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Fleck, A., M. A. Myers, and Vasantha Nagendran. ""NEGATIVE" ACUTE PHASE PROTEINS:- AN INTERLEUKIN 1 INDEPENDENT MECHANISM?" In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-005.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Dinarello, Charles A. "THE BIOLOGICAL EFFECTS OF PURIFIED AND RECOMBINANT HUMAN INTERLEUKIN-1." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-003.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Belch, J. J. F., D. Shapiro, A. Shenkin, and R. D. Sturrock. "PROSTACYCLIN PRODUCTION FROM VASCULAR ENDOTHELIUM IS ENHANCED BY INTERLEUKIN 1." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-006.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Rimsky, L., H. Wakasugi, P. Robin, J. F. Lagabrielle, D. Fradelizi, and J. Bertoglio. "PRODUCTION, PURIFICATION AND BIOLOGICAL ACTIVITIES OF NATURAL HUMAN INTERLEUKIN 2." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-011.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Huland, E., H. Huland, and H. Klosterhalfen. "Interleukin-2 induzierte Immunpotenzierung: Ein neues therapeutisches Modell zur Behandlung des fortgeschrittenen Blasenkrebses." In 40. Tagung, 28. September–1. Oktober 1988, Saarbrücken. Springer Berlin Heidelberg, 1989. http://dx.doi.org/10.1007/978-3-642-83800-2_299.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Whicher, J. T., and C. Westacott. "ARE THERE DEFECTS IN THE PRODUCTION OF INTERLEUKIN 1 IN DISEASE." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-004.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Lidereau, R., J. Oglobine, J. Amione, et al. "INTERLEUKIN 2 (IL2) PRODUCTION BY LYMPHOCYTES OF HUMAN BREAST CANCER PATIENTS." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-012.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Damais, C., G. Riveau, M. Parant, and L. Chedid. "MURABUTIDE INDUCED PRODUCTION OF NON PYROGENIC INTERLEUKIN 1 BY HUMAN MONOCYTES AND RABBIT MACROPHAGES." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-008.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Shapiro, D., J. J. F. Belch, R. D. Sturrock, and A. Shenkin. "EFFECTS OF DRUGS ALTERING ARACHIDONIC ACID METABOLISM ON INTERLEUKIN 1 RELEASE FROM MONOCYTE-LIKE CELLS." In Proceedings of the Third Symposium, Lyon, France, June 26–28, 1985, edited by Jacques Bienvenu, J. A. Grimaud, and Philippe Laurent. De Gruyter, 1986. http://dx.doi.org/10.1515/9783110860757-007.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Streszczenia konferencji na temat "Interleukin-28"

1

Mcguire, Jeremy J., Leah Cook, Jeremy Frieling, et al. "Abstract 1992: Mesenchymal stem cell-derived interleukin-28 can drive the selection of apoptosis resistant bone metastatic prostate cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-1992.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

2

Mcguire, Jeremy J., Leah Cook, Jeremy Frieling, et al. "Abstract 1992: Mesenchymal stem cell-derived interleukin-28 can drive the selection of apoptosis resistant bone metastatic prostate cancer." In Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1992.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

3

Wiegertjes, R., A. van Caam, H. van Beuningen, P. van der Kraan, F. van de Loo, and E. Blaney Davidson. "P078 Transforming growth factor-beta dampens pro-inflammatory interleukin-6 signaling in chondrocytes by decreasing the interleukin-6 receptor." In 39th European Workshop for Rheumatology Research, 28 February–2 March 2019, Lyon, France. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2019.67.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

4

Cavalli, G., M. Gresnigt, T. Nemkov, et al. "P087 The anti-inflammatory cytokine interleukin 37 is an endogenous inhibitor of trained immunity." In 39th European Workshop for Rheumatology Research, 28 February–2 March 2019, Lyon, France. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2019.76.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

5

Mermoud, L., D. Talabot-Ayer, N. Brembilla, J. Julia Borowczyk-Michalowska, and G. Palmer. "P069 Constitutive overexpression of interleukin 38 has a negative impact on human NHK keratinocyte fitness." In 39th European Workshop for Rheumatology Research, 28 February–2 March 2019, Lyon, France. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2019.58.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

6

Ojeda, Laura, Cristina Cirauqui, Sonia Molina-Pinelo, et al. "Abstract 5247: Interleukin-11 could be a novel therapeutic target for lung adenocarcinoma patients." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-5247.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

7

Labadie, Kevin P., Shannon A. Kreuser, Katherine J. Brempelis, et al. "Abstract 5545: Neutralization of interleukin-10 by genetically engineered macrophages increase cancer cell death in metastatic colorectal cancer." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-5545.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

8

Ju, Cunxiang, Mingkun Zhang, Dan Wu, et al. "Abstract 5613: Human interleukin 15 (IL15) humanized NCG mice support the human natural killer cells reconstitution and development." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-5613.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

9

Yang, Yanping, Jaclyn E. McCloskey, Yogindra Vedvyas, Irene M. Min, Eric von Hofe, and Moonsoo M. Jin. "Abstract 6597: Highly localized, inducible interleukin-12 release augments ICAM-1 CAR T cell activity against solid tumors." In Proceedings: AACR Annual Meeting 2020; April 27-28, 2020 and June 22-24, 2020; Philadelphia, PA. American Association for Cancer Research, 2020. http://dx.doi.org/10.1158/1538-7445.am2020-6597.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

10

Aarts, J., D. Roeleveld, B. Walgreen, et al. "P086 Systemic overexpression of interleukin-22 induces expression of the negative immune-regulator SOCS3 and potently reduces collagen-induced arthritis in mice." In 39th European Workshop for Rheumatology Research, 28 February–2 March 2019, Lyon, France. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2018-ewrr2019.75.

Pełny tekst źródła

Style APA, Harvard, Vancouver, ISO itp.

Oferujemy zniżki na wszystkie plany premium dla autorów, których prace zostały uwzględnione w tematycznych zestawieniach literatury. Skontaktuj się z nami, aby uzyskać unikalny kod promocyjny!